Glomus jugulare tumor: Tumor control and complications after stereotactic radiosurgery

Robert L. Foote, Bruce E. Pollock, Deborah A. Gorman, Paula J. Schomberg, Scott L. Stafford, Michael J. Link, Robert W. Kline, Scott E. Strome, Jan L. Kasperbauer, Kerry D. Olsen

Research output: Contribution to journalArticlepeer-review

99 Scopus citations


Background. We evaluated toxicity and long-term efficacy of stereotactic radiosurgery in patients with symptomatic or progressive glomus jugulare tumors. Methods. Twenty-five consecutive patients (age, 30-88 years; 17 women, 8 men) who underwent stereotactic radiosurgery with the Leksell Gamma Knife (dose, 12-18 Gy) were prospectively followed. MRI and clinical examinations were performed at 6 months and 1, 2, and 3 years, and then every 2 years. Results. None of the tumors increased in size, 17 were stable, and 8 decreased (median imaging follow-up, 35 months; range, 10-113 months). Symptoms subsided in 15 patients (60%); vertigo occurred in 1, but balance improved with vestibular training (median clinical follow-up, 37 months; range, 11-118 months). No other new or progressive neuropathy of cranial nerves V-XII developed. Conclusions. Stereotactic radiosurgery can achieve excellent tumor control with low risk of morbidity in the treatment of glomus jugulare tumors. The lower cranial nerves can safely tolerate a radiosurgical dose of 12 to 18 Gy.

Original languageEnglish (US)
Pages (from-to)332-339
Number of pages8
JournalHead and Neck
Issue number4
StatePublished - Jan 1 2002


  • Gamma knife
  • Glomus jugulare tumor
  • Prospective study
  • Stereotactic radiosurgery

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Glomus jugulare tumor: Tumor control and complications after stereotactic radiosurgery'. Together they form a unique fingerprint.

Cite this